Median Diagnostics

Chuncheon, South Korea Founded: 1999 • Age: 27 yrs Listed
Immune diagnostic reagents for veterinary applications are developed.

About Median Diagnostics

Median Diagnostics is a company based in Chuncheon (South Korea) founded in 1999. Median Diagnostics operates in a competitive market with competitors including Heska, Pictor, vetevo, Fluxergy and Bionote, among others.

  • Headquarter Chuncheon, South Korea
  • Stage Public
  • Sectors
    Healthcare
  • Email
    ••••••••
  • Phone
    •••• ••••
  • Website mediandiagnostics.com
  • Social LinkedIn YouTube
  • Legal Name Median Diagnostics Inc.
Key Metrics
  • Annual Revenue
    $8.29 M (USD)
    -1.85
    as on Dec 31, 2025
  • Net Profit
    $1.64 M (USD)
    97.38
    as on Dec 31, 2025
  • EBITDA
    $1.52 M (USD)
    196
    as on Dec 31, 2025
  • Investors

Apps and channels of Median Diagnostics

its YouTube channel 메디안디노스틱 MEDIAN Diagnostics has 103 subscribers and 20 videos.

메디안디노스틱 MEDIAN Diagnostics
YouTube 103 subscribers 20 videos Howto & Style
Open channel

Videos from Median Diagnostics

The most watched videos on Median Diagnostics's YouTube channel, 메디안디노스틱 MEDIAN Diagnostics (103 subscribers). Click a video to play it here.

메디안디노스틱 코로나19 자가검사키트 사용방법
9.6K views
메디안디노스틱 기업홍보영상
2.1K views
TEST PROCEDURE OF FMDV 3DiFF/PAN Ag Rapid Kit
2K views
How to use VDRG® BoviDia 5 Ag Rapid Kit
608 views

More on 메디안디노스틱 MEDIAN Diagnostics .

Funding Insights of Median Diagnostics

  • Total Rounds 1
  • Investors Count 1

All 1 funding rounds of Median Diagnostics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jun 2016–Private Equity Round–STIC Investments
–
Valuation history

1 investors in total: 1 institutional.

Investors in Median Diagnostics

Median Diagnostics has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include STIC Investments.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Private equity and innovation services are provided by STIC Investments.
–stic.co.krSeoul, South Korea
Premium access

Investor details for Median Diagnostics

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Median Diagnostics

1 people are tracked at Median Diagnostics (1 in leadership).

NameRoleGroup
Oh Jin-sik
CEOLeadership
Premium access

Complete people profiles for Median Diagnostics

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

IPO & Listings of Median Diagnostics

Median Diagnostics is a publicly listed company on the KRX with ticker symbol 233250 in South Korea, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date26 Jun 2017
  • Listed onKRX: 233250
  • Listed entityMedian Diagnostics Inc.
  • Exchange sectorHealth technology
  • ISINKR7233250000
  • Share price4,900.00 KRW · 2026-10-02
  • Market capitalisation8,040,625,620.00 KRW
  • Volume (last session)12

Financials of Median Diagnostics

Exchange-reported annual figures
YearRevenueNet incomeEBITDA
202511.97B KRW2.37B KRW2.19B KRW
202412.19B KRW1.20B KRW740.6M KRW
202311.89B KRW-1.37B KRW-1.39B KRW
202224.83B KRW325.2M KRW489.0M KRW
202114.26B KRW2.39B KRW3.19B KRW
Premium access

Detailed financial statements for Median Diagnostics

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of Median Diagnostics

3 dated milestones of Median Diagnostics across 18 years, from founding to its latest funding, stage changes and deals.

  1. Founded Median Diagnostics is founded.
  2. Funding First funding round.
  3. IPO Lists on the stock exchange (IPO).

Competitors of Median Diagnostics

Median Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Heska, Pictor, vetevo, Fluxergy and Bionote, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
heska.com1988Fort Collins, United States$6.5M361
Provider of diagnostic solutions for pet care
pictordx.com2005Auckland, New Zealand$11.1M–
Immunodiagnostic products are developed via multiplexed assays.
vetevo.de2016Berlin, Germany–39
Diagnostic services for pets are booked online with results delivered.
fluxergy.com2011Irvine, United States–74
Provides diagnostic devices and software for clinical and veterinary point-of-care testing.
bionote.com2019Big Lake, United States–6
Point-of-care testing devices are supplied for animal health diagnostics.
orivet.com2010St Kilda, Australia––
Offers DNA tests for pets to screen diseases, traits, and confirm parentage.
repropharmvet.com2018Nouzilly, France––
Ovulation tests and diagnostic tools for cattle reproduction are provided.
accessiblediagnostics.com2014Greenville, United States$548,500–
Delivers comprehensive glucose monitoring device solutions.
accuplexdiagnostics.com2011Maynooth, Ireland––
Developer of rapid diagnostic tests for diseases and conditions in veterinary, human, and research applications
Premium access

Detailed competitors of Median Diagnostics

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Median Diagnostics

The website of Median Diagnostics (mediandiagnostics.com) receives about 3.4K visits a month.

  • Monthly visits
    3.4K

    ▲ 4.1% vs previous month

Similar websites

Websites whose visitors overlap most with Median Diagnostics. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
konex.or.kr
konex.or.kr
100%
–#3,491,691–

Latest news on Median Diagnostics

Premium access

Complete news archive for Median Diagnostics

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Similar companies to Median Diagnostics

10 companies that operate in the same segment as Median Diagnostics (Veterinary Digital Health), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Practice and prescription management software is provided for veterinary professionals.
2010Portland, Oregon, United StatesUSD 291.64 M––
Animal medicines, vaccines, and diagnostics are manufactured and supplied.
2012Brussels, Brussels-capital Region, Belgium–––
Veterinary pharmacy services are delivered by VetSource to practices.
2005Portland, Oregon, United StatesUSD 81.25 M––
Animal health therapeutics are developed and supplied globally by Ceva.
1999Libourne, Nouvelle-aquitaine, FranceUSD 214.35 M––
Digital platform for pet insurance
2020Stockholm, SwedenUSD 114.08 M––
App based platform providing veterinary services and clinical management solutions for veterinarians
2018Beverly Hills, California, United StatesUSD 58.81 M––
Online client communication platform for veterinary doctors
2013San Diego, California, United StatesUSD 14.11 MUSD 14.38 M1
Virtual veterinary care is provided via an app platform.
2018Los Angeles, California, United StatesUSD 210 M–163
Comprehensive customer engagement platform for veterinary clinics is provided.
2015Austin, Texas, United StatesUSD 50.3 M––
Veterinary appointments are booked via an online platform.
2017Brooklyn, New York, United StatesUSD 243 M–64
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Median Diagnostics

Median Diagnostics was founded in 1999 and raised its 1st funding round 17 years after it was founded.

Median Diagnostics is headquartered in Chuncheon, South Korea. It is registered at Chuncheon, Gangwon, South Korea.

Oh Jin-sik is the current CEO of Median Diagnostics.

Annual revenue of Median Diagnostics is $8.29M as on Dec 31, 2025.

Median Diagnostics was founded in 1999 and operates in the veterinary diagnostics sector. Immune diagnostic reagents are produced, including ELISA kits for swine, ruminants, and poultry, as well as VDRF rapid test kits. Genetic recombination and monoclonal antibody technologies are utilized in these products. The companys activities center on supporting animal health testing through these specialized tools.

Median Diagnostics's top competitors include Pictor, Heska and vetevo.

Yes, Median Diagnostics is publicly traded on KRX under the ticker symbol 233250.

Median Diagnostics has 1 investor. Key investors include STIC Investments.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available